T1	Drug	113	134	AZD0530 (saracatinib)	UMLS:C2828242	saracatinib
T75	Disease	138	157	Alzheimer’s disease	UMLS:C0002395	Alzheimer's Disease
T76	Disease	220	244	Alzheimer’s disease (AD)	UMLS:C0002395	Alzheimer's Disease
T77	Disease	376	378	AD	UMLS:C0002395	Alzheimer's Disease
T78	Disease	627	629	AD	UMLS:C0002395	Alzheimer's Disease
T79	Disease	739	741	AD	UMLS:C0002395	Alzheimer's Disease
T2	Drug	818	825	AZD0530	UMLS:C2828242	saracatinib
T80	Disease	925	944	mild-to-moderate AD	UMLS:C0002395	Alzheimer's Disease
T3	Drug	1057	1064	AZD0530	UMLS:C2828242	saracatinib
T81	Disease	1068	1070	AD	UMLS:C0002395	Alzheimer's Disease
T116	Measure	1085	1121	Mini-Mental State Examination (MMSE)	UMLS:C0451306	Mini-mental state examination
T117	ScaleMin	1142	1144	16	null	null
T118	ScaleMax	1148	1150	26	null	null
T4	Drug	1255	1262	AZD0530	UMLS:C2828242	saracatinib
T5	Drug	1450	1457	AZD0530	UMLS:C2828242	saracatinib
T119	Measure	1527	1584	Alzheimer’s Disease Assessment Scale – cognitive subscale	UMLS:C3539026	Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire
T120	Measure	1586	1590	MMSE	UMLS:C0451306	Mini-mental state examination
T121	Measure	1670	1696	Neuropsychiatric Inventory	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T122	Measure	1702	1747	Clinical Dementia Rating Scale – Sum of Boxes	UMLS:C0451074	Clinical dementia rating scale
T6	Drug	1851	1858	AZD0530	UMLS:C2828242	saracatinib
T7	Drug	1943	1950	AZD0530	UMLS:C2828242	saracatinib
T123	Phenotype	2009	2033	congestive heart failure	HPO:HP:0001635	Congestive heart failure
T8	Drug	2136	2143	AZD0530	UMLS:C2828242	saracatinib
T125	Phenotype	2249	2264	memory deficits	HPO:HP:0002354	Memory impairment
T9	Drug	2318	2325	AZD0530	UMLS:C2828242	saracatinib
T10	Drug	2423	2430	AZD0530	UMLS:C2828242	saracatinib
T82	Disease	2486	2505	mild-to-moderate AD	UMLS:C0002395	Alzheimer's Disease
T11	Drug	2705	2712	AZD0530	UMLS:C2828242	saracatinib
T83	Disease	2660	2662	AD	UMLS:C0002395	Alzheimer's Disease
T84	Disease	2748	2750	AD	UMLS:C0002395	Alzheimer's Disease
T85	Disease	2904	2928	Alzheimer’s disease (AD)	UMLS:C0002395	Alzheimer's Disease
T86	Disease	3035	3037	AD	UMLS:C0002395	Alzheimer's Disease
T87	Disease	3264	3266	AD	UMLS:C0002395	Alzheimer's Disease
T88	Disease	3853	3855	AD	UMLS:C0002395	Alzheimer's Disease
T127	Phenotype	4588	4624	spatial learning and memory deficits	null	null
T128	Phenotype	4588	4624	spatial learning and memory deficits	HPO:HP:0002354	Memory impairment
T129	Phenotype	4626	4642	reduced survival	null	null
T131	Phenotype	4669	4681	synapse loss	null	null
T132	Phenotype	4683	4711	serotonin fiber degeneration	null	null
T89	Disease	4871	4873	AD	UMLS:C0002395	Alzheimer's Disease
T90	Disease	4755	4757	AD	UMLS:C0002395	Alzheimer's Disease
T91	Disease	5214	5216	AD	UMLS:C0002395	Alzheimer's Disease
T92	Disease	5437	5439	AD	UMLS:C0002395	Alzheimer's Disease
T93	Disease	5510	5512	AD	UMLS:C0002395	Alzheimer's Disease
T12	Drug	5514	5535	Saracatinib (AZD0530)	UMLS:C2828242	saracatinib
T14	Drug	6063	6070	AZD0530	UMLS:C2828242	saracatinib
T133	Disease	6112	6124	solid tumors	UMLS:C0280100	Solid tumour
T13	Drug	6202	6209	AZD0530	UMLS:C2828242	saracatinib
T147	Treatment	6350	6364	cancer therapy	UMLS:C0920425	cancer treatment
T15	Drug	6611	6632	AZD0530 (saracatinib)	UMLS:C2828242	saracatinib
T94	Disease	6636	6655	mild-to-moderate AD	UMLS:C0002395	Alzheimer's Disease
T16	Drug	6726	6733	AZD0530	UMLS:C2828242	saracatinib
T96	Disease	7406	7417	AD dementia	UMLS:C0002395	Alzheimer's Disease
T135	Gender	7327	7330	Men	Gender:C0086582	male
T136	Gender	7335	7340	women	Gender:C0015780	female
T137	AgeGroup	7341	7354	aged 50 to 90	AgeGroups:C0683973	middle aged adult (45-64 years)
T138	AgeGroup	7341	7354	aged 50 to 90	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T139	AgeGroup	7341	7354	aged 50 to 90	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T140	Measure	7516	7552	Mini-Mental State Examination (MMSE)	UMLS:C0451306	Mini-mental state examination
T141	ScaleMin	7567	7569	16	null	null
T142	ScaleMax	7573	7575	26	null	null
T143	Drug	7733	7758	Cholinesterase inhibitors	UMLS:C0008425	Cholinesterase Inhibitors
T156	Drug	7763	7772	memantine	DrugBank:DB01043	Memantine
T145	ScaleMax	7858	7875	score less than 6	null	null
T146	Measure	7883	7909	Geriatric Depression Scale	UMLS:C0451184	Geriatric depression scale (assessment scale)
T147	ScaleMax	7919	7942	less than or equal to 4	null	null
T148	Measure	7950	7974	Modified Hachinski Scale	UMLS:C3826978	Modified Hachinski Ischemic Scale-NACC Version Questionnaire
T97	Disease	8307	8309	AD	UMLS:C0002395	Alzheimer's Disease
T149	Disease	8277	8295	neurologic disease	UMLS:C0027765	nervous system disorder
T150	Phenotype	8403	8412	infection	UMLS:C3714514	Infection
T151	Phenotype	8414	8424	infarction	UMLS:C0021308	Infarction
T152	Phenotype	8435	8448	focal lesions	null	null
T153	Phenotype	8460	8476	multiple lacunes	UMLS:C0241970	lacune
T154	Phenotype	8480	8525	lacunes in a brain region critical for memory	null	null
T155	Disease	8554	8567	schizophrenia	UMLS:C0036341	Schizophrenia
T156	Phenotype	9017	9065	abnormalities in vitamin B12 or thyroid function	UMLS:C0855981	Vitamin B12 abnormal
T157	Phenotype	9017	9065	abnormalities in vitamin B12 or thyroid function	HPO:HP:0002926	Abnormality of thyroid physiology
T158	Phenotype	9109	9120	neutropenia	HPO:HP:0001875	Neutropenia
T159	Phenotype	9175	9191	thrombocytopenia	HPO:HP:0001873	Thrombocytopenia
T161	Disease	9233	9277	current blood clotting or bleeding disorder,	UMLS:C0005779	Blood Coagulation Disorders
T160	Phenotype	9295	9351	abnormal prothrombin time or partial thromboplastin time	UMLS:C0580412	Prothrombin time abnormal
T162	Phenotype	9295	9351	abnormal prothrombin time or partial thromboplastin time	HPO:HP:0003645	Prolonged partial thromboplastin time
T163	Disease	9633	9658	interstitial lung disease	UMLS:C0206062	Lung Diseases, Interstitial
T185	Drug	9840	9860	typical neuroleptics	UMLS:C0040615	Antipsychotic Agents
T165	Drug	9862	9881	narcotic analgesics	UMLS:C0027409	Narcotic Analgesics
T166	Drug	9883	9906	Parkinson’s medications	UMLS:C0003405	Antiparkinson Agents
T168	Drug	9937	9999	medications with significant central anticholinergic activity,	UMLS:C0242896	Anticholinergic Agents
T190	Drug	10003	10011	warfarin	DrugBank:DB00682	Warfarin
T170	Drug	10178	10195	CYP3A4 inhibitors	UMLS:C3850053	Cytochrome P-450 CYP3A4 Inhibitors
T171	Drug	10207	10217	atazanavir	DrugBank:DB01072	Atazanavir
T172	Drug	10219	10228	indinavir	DrugBank:DB00224	Indinavir
T173	Drug	10230	10239	ritonavir	DrugBank:DB00503	Ritonavir
T174	Drug	10241	10251	saquinavir	DrugBank:DB01232	Saquinavir
T175	Drug	10253	10263	nelfinavir	DrugBank:DB00220	Nelfinavir
T176	Drug	10265	10277	ketoconazole	DrugBank:DB01026	Ketoconazole
T177	Drug	10279	10291	itraconazole	DrugBank:DB01167	Itraconazole
T178	Drug	10293	10307	clarithromycin	DrugBank:DB01211	Clarithromycin
T179	Drug	10309	10322	telithromycin	DrugBank:DB00976	Telithromycin
T180	Drug	10328	10338	nefazodone	DrugBank:DB01149	Nefazodone
T181	Drug	10350	10365	CYP3A4 inducers	UMLS:C3850041	Cytochrome P-450 CYP3A4 Inducers
T182	Drug	10377	10387	rifampicin	DrugBank:DB01045	Rifampicin
T183	Drug	10389	10398	phenytoin	DrugBank:DB00252	Phenytoin
T184	Drug	10400	10413	phenobarbital	DrugBank:DB01174	Phenobarbital
T185	Drug	10419	10432	carbamazepine	DrugBank:DB00564	Carbamazepine
T186	Drug	10445	10462	CYP3A4 substrates	null	null
T187	Drug	10473	10483	colchicine	DrugBank:DB01394	Colchicine
T188	Drug	10485	10497	cyclosporine	DrugBank:DB00091	Cyclosporine
T189	Drug	10499	10511	disopyramide	DrugBank:DB00280	Disopyramide
T190	Drug	10513	10524	fluticasone	DrugBank:DB00588	Fluticasone Propionate
T191	Drug	10526	10535	quinidine	DrugBank:DB00908	Quinidine
T192	Drug	10537	10548	vinblastine	DrugBank:DB00570	Vinblastine
T193	Drug	10550	10561	vincristine	DrugBank:DB00541	Vincristine
T194	Drug	10579	10589	sildenafil	DrugBank:DB00203	Sildenafil
T195	Drug	10591	10600	tadalafil	DrugBank:DB00820	Tadalafil
T196	Drug	10606	10616	vardenafil	DrugBank:DB00862	Vardenafil
T17	Drug	11120	11127	AZD0530	UMLS:C2828242	saracatinib
T18	Drug	11491	11498	AZD0530	UMLS:C2828242	saracatinib
T98	Disease	11516	11518	AD	UMLS:C0002395	Alzheimer's Disease
T99	Disease	11643	11645	AD	UMLS:C0002395	Alzheimer's Disease
T19	Drug	11700	11707	AZD0530	UMLS:C2828242	saracatinib
T101	Disease	11874	11876	AD	UMLS:C0002395	Alzheimer's Disease
T20	Drug	12138	12145	AZD0530	UMLS:C2828242	saracatinib
T100	Disease	12162	12164	AD	UMLS:C0002395	Alzheimer's Disease
T21	Drug	12323	12330	AZD0530	UMLS:C2828242	saracatinib
T22	Drug	12707	12714	AZD0530	UMLS:C2828242	saracatinib
T197	Measure	12821	12838	MMSE examinations	UMLS:C0451306	Mini-mental state examination
T198	Measure	13190	13194	MMSE	UMLS:C0451306	Mini-mental state examination
T23	Drug	13266	13273	AZD0530	UMLS:C2828242	saracatinib
T199	Disease	13328	13353	interstitial lung disease	UMLS:C0206062	Lung Diseases, Interstitial
T201	Phenotype	13489	13507	pulmonary symptoms	UMLS:C0037090	Signs and Symptoms, Respiratory
T202	Measure	13644	13712	Alzheimer’s Disease Assessment Scale – cognitive subscale (ADAS-cog)	UMLS:C3539026	Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire
T203	Measure	13719	13723	MMSE	UMLS:C0451306	Mini-mental state examination
T204	Measure	13824	13856	Neuropsychiatric Inventory (NPI)	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T205	Measure	13867	13922	Clinical Dementia Rating Scale – Sum of Boxes (CDR-SOB)	UMLS:C0451074	Clinical dementia rating scale
T206	Measure	13933	13937	MMSE	UMLS:C0451306	Mini-mental state examination
T24	Drug	14660	14667	AZD0530	UMLS:C2828242	saracatinib
T207	Disease	15216	15224	leukemia	UMLS:C0023418	leukemia
T25	Drug	15425	15432	AZD0530	UMLS:C2828242	saracatinib
T209	Drug	15437	15444	STI-571	DrugBank:DB00619	Imatinib
T210	Demographic	16156	16159	USA	UMLS:C0041703	United States
T211	Demographic	16241	16244	USA	UMLS:C0041703	United States
T26	Drug	16478	16485	AZD0530	UMLS:C2828242	saracatinib
T208	Drug	16490	16493	STI	null	null
T212	Demographic	16692	16695	USA	UMLS:C0041703	United States
T27	Drug	16861	16868	AZD0530	UMLS:C2828242	saracatinib
T28	Drug	17424	17431	AZD0530	UMLS:C2828242	saracatinib
T213	Measure	17551	17555	MMSE	UMLS:C0451306	Mini-mental state examination
T214	Measure	17557	17565	ADAS-cog	UMLS:C3539026	Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire
T215	Measure	17567	17574	CDR-SOB	UMLS:C0451074	Clinical dementia rating scale
T216	Measure	17586	17589	NPI	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T217	Measure	17689	17692	NPI	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T219	Measure	18137	18141	MMSE	UMLS:C0451306	Mini-mental state examination
T220	Phenotype	18151	18187	abnormal thyroid stimulating hormone	null	null
T221	Phenotype	18193	18209	thalamic infarct	UMLS:C1611171	Thalamic infarction
T222	Phenotype	18219	18242	abnormal liver function	HPO:HP:0001410	Decreased liver function
T223	Gender	18491	18497	female	Gender:C0015780	female
T224	AgeGroup	18521	18535	55 to 86 years	AgeGroups:C0683973	middle aged adult (45-64 years)
T225	AgeGroup	18521	18535	55 to 86 years	AgeGroups:C0001792	aged adult (elderly; 65-80 years)
T226	AgeGroup	18521	18535	55 to 86 years	AgeGroups:C0001795	adult, aged over 80 (>80 years)
T227	Ethnicity	18588	18597	Caucasian	UMLS:C0043157	Caucasians
T228	Measure	18617	18621	MMSE	UMLS:C0451306	Mini-mental state examination
T229	AgeGroup	18797	18802	older	null	null
T230	Measure	18828	18832	MMSE	UMLS:C0451306	Mini-mental state examination
T30	Drug	21113	21120	AZD0530	UMLS:C2828242	saracatinib
T102	Disease	21204	21223	mild-to-moderate AD	UMLS:C0002395	Alzheimer's Disease
T31	Drug	21260	21267	AZD0530	UMLS:C2828242	saracatinib
T32	Drug	21852	21859	AZD0530	UMLS:C2828242	saracatinib
T251	Phenotype	21752	21760	diarrhea	HPO:HP:0002014	Diarrhea
T252	Phenotype	21762	21770	headache	HPO:HP:0002315	Headache
T253	Phenotype	21772	21779	fatigue	HPO:HP:0012378	Fatigue
T254	Phenotype	21785	21791	nausea	HPO:HP:0002018	Nausea
T34	Drug	22955	22962	AZD0530	UMLS:C2828242	saracatinib
T278	Phenotype	23035	23042	fatigue	HPO:HP:0012378	Fatigue
T279	Phenotype	23044	23052	anorexia	HPO:HP:0002039	Anorexia
T280	Phenotype	23058	23066	myalgias	HPO:HP:0003326	Myalgia
T281	Phenotype	23081	23100	shortness of breath	HPO:HP:0002094	Dyspnea
T282	Phenotype	23104	23119	low-grade fever	HPO:HP:0011134	Low-grade fever
T283	Phenotype	23248	23272	congestive heart failure	HPO:HP:0001635	Congestive heart failure
T291	Phenotype	23290	23299	pneumonia	HPO:HP:0002090	Pneumonia
T286	Drug	23479	23488	diuretics	UMLS:C0012798	Diuretics
T287	Drug	23493	23504	antibiotics	UMLS:C0003232	Antibiotics
T35	Drug	23750	23757	AZD0530	UMLS:C2828242	saracatinib
T288	Phenotype	23885	23910	elevated serum creatinine	HPO:HP:0003259	Elevated serum creatinine
T289	Phenotype	23965	23993	worsened renal insufficiency	HPO:HP:0000083	Renal insufficiency
T290	Phenotype	24059	24080	hematological changes	null	null
T36	Drug	24237	24244	AZD0530	UMLS:C2828242	saracatinib
T37	Drug	24295	24302	AZD0530	UMLS:C2828242	saracatinib
T38	Drug	25014	25021	AZD0530	UMLS:C2828242	saracatinib
T39	Drug	25077	25084	AZD0530	UMLS:C2828242	saracatinib
T40	Drug	25449	25456	AZD0530	UMLS:C2828242	saracatinib
T41	Drug	25758	25765	AZD0530	UMLS:C2828242	saracatinib
T103	Disease	25105	25107	AD	UMLS:C0002395	Alzheimer's Disease
T291	Phenotype	25191	25209	memory impairments	HPO:HP:0002354	Memory impairment
T292	Drug	25325	25332	AZD0530	UMLS:C2828242	saracatinib
T293	Phenotype	25621	25636	memory deficits	HPO:HP:0002354	Memory impairment
T42	Drug	26103	26110	AZD0530	UMLS:C2828242	saracatinib
T43	Drug	26190	26197	AZD0530	UMLS:C2828242	saracatinib
T44	Drug	26228	26235	AZD0530	UMLS:C2828242	saracatinib
T294	Measure	26462	26466	MMSE	UMLS:C0451306	Mini-mental state examination
T295	Measure	26547	26551	MMSE	UMLS:C0451306	Mini-mental state examination
T296	Measure	26733	26741	ADAS-cog	UMLS:C3539026	Alzheimer's Disease Assessment Scale-Cognitive CDISC Version Questionnaire
T297	Measure	26753	26760	CDR-SOB	UMLS:C0451074	Clinical dementia rating scale
T298	Measure	26766	26769	NPI	UMLS:C3539727	Neuropsychiatric Inventory Questionnaire
T45	Drug	27032	27039	AZD0530	UMLS:C2828242	saracatinib
T104	Disease	27473	27501	mild-to-moderate AD dementia	UMLS:C0002395	Alzheimer's Disease
T46	Drug	27631	27638	AZD0530	UMLS:C2828242	saracatinib
T47	Drug	27753	27760	AZD0530	UMLS:C2828242	saracatinib
T48	Drug	28067	28074	AZD0530	UMLS:C2828242	saracatinib
T303	Phenotype	28090	28103	decrease sCTX	null	null
T49	Drug	28393	28400	AZD0530	UMLS:C2828242	saracatinib
T50	Drug	28270	28277	AZD0530	UMLS:C2828242	saracatinib
T304	Phenotype	28209	28231	decrease in serum sCTX	null	null
T305	Drug	28312	28319	AZD0530	UMLS:C2828242	saracatinib
T306	Phenotype	28401	28467	reduces serum cross-linked C-telopeptide of type 1 collagen (sCTX)	null	null
T51	Drug	28850	28857	AZD0530	UMLS:C2828242	saracatinib
T52	Drug	29142	29149	AZD0530	UMLS:C2828242	saracatinib
T53	Drug	29459	29466	AZD0530	UMLS:C2828242	saracatinib
T307	Disease	29607	29615	leukemia	UMLS:C0023418	leukemia
T54	Drug	29782	29789	AZD0530	UMLS:C2828242	saracatinib
T55	Drug	30107	30114	AZD0530	UMLS:C2828242	saracatinib
T56	Drug	30118	30125	STI-571	DrugBank:DB00619	Imatinib
T57	Drug	30455	30462	AZD0530	UMLS:C2828242	saracatinib
T58	Drug	31085	31092	AZD0530	UMLS:C2828242	saracatinib
T59	Drug	31127	31134	AZD0530	UMLS:C2828242	saracatinib
T60	Drug	31019	31026	AZD0530	UMLS:C2828242	saracatinib
T61	Drug	31211	31218	AZD0530	UMLS:C2828242	saracatinib
T62	Drug	31250	31257	AZD0530	UMLS:C2828242	saracatinib
T63	Drug	31339	31346	AZD0530	UMLS:C2828242	saracatinib
T64	Drug	31381	31388	AZD0530	UMLS:C2828242	saracatinib
T65	Drug	31469	31476	AZD0530	UMLS:C2828242	saracatinib
T66	Drug	31505	31512	AZD0530	UMLS:C2828242	saracatinib
T105	Disease	30939	30941	AD	UMLS:C0002395	Alzheimer's Disease
T106	Disease	31602	31604	AD	UMLS:C0002395	Alzheimer's Disease
T107	Disease	31823	31825	AD	UMLS:C0002395	Alzheimer's Disease
T108	Disease	31965	31967	AD	UMLS:C0002395	Alzheimer's Disease
T308	Phenotype	31935	31950	memory deficits	HPO:HP:0002354	Memory impairment
T67	Drug	32108	32115	AZD0530	UMLS:C2828242	saracatinib
T68	Drug	32377	32384	AZD0530	UMLS:C2828242	saracatinib
T109	Disease	33035	33037	AD	UMLS:C0002395	Alzheimer's Disease
T69	Drug	33122	33129	AZD0530	UMLS:C2828242	saracatinib
T309	Disease	33184	33209	interstitial lung disease	UMLS:C0206062	Lung Diseases, Interstitial
T299	Phenotype	33303	33327	congestive heart failure	HPO:HP:0001635	Congestive heart failure
T306	Phenotype	33332	33341	pneumonia	HPO:HP:0002090	Pneumonia
T70	Drug	33470	33477	AZD0530	UMLS:C2828242	saracatinib
T71	Drug	33525	33532	AZD0530	UMLS:C2828242	saracatinib
T110	Disease	33537	33539	AD	UMLS:C0002395	Alzheimer's Disease
T311	Phenotype	33654	33672	pulmonary symptoms	UMLS:C0037090	Signs and Symptoms, Respiratory
T72	Drug	33871	33878	AZD0530	UMLS:C2828242	saracatinib
T111	Disease	33882	33884	AD	UMLS:C0002395	Alzheimer's Disease
T112	Disease	34123	34142	mild-to-moderate AD	UMLS:C0002395	Alzheimer's Disease
T312	Drug	33900	33909	Masitinib	UMLS:C2351398	masitinib
T313	Demographic	34088	34094	France	UMLS:C0016674	France
T314	Drug	34406	34415	masitinib	UMLS:C2351398	masitinib
T113	Disease	34560	34562	AD	UMLS:C0002395	Alzheimer's Disease
T73	Drug	34609	34616	AZD0530	UMLS:C2828242	saracatinib
T114	Disease	34671	34673	AD	UMLS:C0002395	Alzheimer's Disease
T74	Drug	34885	34892	AZD0530	UMLS:C2828242	saracatinib
T115	Disease	34865	34867	AD	UMLS:C0002395	Alzheimer's Disease
R1	hasScale	1085	1121	Measure	1142	1144	ScaleMin
R2	hasScale	1085	1121	Measure	1148	1150	ScaleMax
R3	hasScale	7516	7552	Measure	7567	7569	ScaleMin
R4	hasScale	7516	7552	Measure	7573	7575	ScaleMax
R5	hasScale	7883	7909	Measure	7858	7875	ScaleMax
R6	hasScale	7950	7974	Measure	7919	7942	ScaleMax
